These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3573770)
1. Augmentation of lymphoproliferative activity of tumor-bearing BALB/c mice to soluble tumor antigens by surgical manipulation: the possible role of macrophages. Laing CA; Japal KM; Baker ME J Surg Oncol; 1987 May; 35(1):1-6. PubMed ID: 3573770 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of the reactivity of subpopulations of spleen cells of mice bearing virus-induced mammary tumors to syngeneic antigenic extracts in vitro. Supportive and suppressive effects of macrophages. Laing CA Cancer Immunol Immunother; 1982; 13(2):98-104. PubMed ID: 6297714 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the incidence of metastasis in tumor-resected mice. Influence of soluble tumor extract and splenectomy. Klein S; de Bonaparte YP; de D'Elia I Invasion Metastasis; 1985; 5(5):309-16. PubMed ID: 4030247 [TBL] [Abstract][Full Text] [Related]
4. Differences in immune responses to tumor induced in syngeneic hosts by injection of hybrid and parental tumor cells. Kambe M; Rou K; Tachibana T Tohoku J Exp Med; 1994 Sep; 174(1):71-83. PubMed ID: 7863505 [TBL] [Abstract][Full Text] [Related]
5. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice. Kurata S; Tsuchiya T; Norimura T; Yamashita U J Immunol; 1983 Jan; 130(1):496-500. PubMed ID: 6600195 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice. Lopez DM; Sigel MM; Charyulu VL J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573 [TBL] [Abstract][Full Text] [Related]
7. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995 [TBL] [Abstract][Full Text] [Related]
8. Immunoregulation in experimental Schistosomiasis. III. Role of macrophages in soluble egg antigen-induced chronic spleen cell augmentation of baseline lymphocyte reactivity. Kayes SG; Colley DG Cell Immunol; 1984 Jan; 83(1):161-9. PubMed ID: 6420077 [TBL] [Abstract][Full Text] [Related]
9. Unrestricted T cell-mediated cytotoxicity to major histocompatibility antigen generated with tumor hybrid cells. Kambe M; Tachibana T Tohoku J Exp Med; 1994 Sep; 174(1):85-93. PubMed ID: 7863506 [TBL] [Abstract][Full Text] [Related]
10. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804 [TBL] [Abstract][Full Text] [Related]
11. Reactivity of subpopulations of mouse spleen cells to concanavalin A in vitro. Laing CA; Walters CS Med Pediatr Oncol; 1983; 11(4):233-7. PubMed ID: 6888322 [TBL] [Abstract][Full Text] [Related]
12. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
13. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation. Rudczynski AB; Mortensen RF J Natl Cancer Inst; 1978 Jan; 60(1):205-11. PubMed ID: 203703 [TBL] [Abstract][Full Text] [Related]
14. Suppressor macrophages in tumor-bearing mice. Inconsistency between in vivo and in vitro findings? Forni G; Giovarelli M; Lanfrancone L; Varesio L Int J Cancer; 1982 Jun; 29(6):695-8. PubMed ID: 6213570 [TBL] [Abstract][Full Text] [Related]
15. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. Watson GA; Fu YX; Lopez DM J Leukoc Biol; 1991 Feb; 49(2):126-38. PubMed ID: 1991996 [TBL] [Abstract][Full Text] [Related]
16. Expression of differentiation antigens cross-reactive with Ly-6.2 alloantigens on MM102 mouse mammary tumor cells. Kinouchi T; Fujiwara H; Hamaoka T Gan; 1982 Oct; 73(5):758-65. PubMed ID: 6984683 [TBL] [Abstract][Full Text] [Related]
17. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. Zou JP; Shimizu J; Ikegame K; Yamamoto N; Ono S; Fujiwara H; Hamaoka T J Immunol; 1992 Jan; 148(2):648-55. PubMed ID: 1345922 [TBL] [Abstract][Full Text] [Related]
18. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials. Lopez DM; Paul RD J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565 [No Abstract] [Full Text] [Related]
19. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. Fu YX; Watson GA; Kasahara M; Lopez DM J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777 [TBL] [Abstract][Full Text] [Related]
20. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. Sinha P; Clements VK; Ostrand-Rosenberg S J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]